ALLR · Insider Trading
Allarity Therapeutics, Inc. Common Stock
Every open-market purchase and sale reported by ALLR officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-10-09 | Jeremy R. Graff | See Remarks | MIXED | +55,214 | −$35.20K |
| 2026-05-14 | Thomas Jensen | CEO | A | +200,000 | — |
| 2026-05-11 | Jesper Hoeiland | Director | A | +25,000 | — |
| 2026-05-07 | Gerald W. McLaughlin | Director | A | +45,000 | — |
| 2026-01-16 | Jeremy R. Graff | See Remarks | A | +133,333 | — |
| 2025-10-02 | Jeremy R. Graff | See Remarks | MIXED | +24,881 | −$23.09K |
| 2025-01-24 | Joseph Walter Vazzano | Director | A | +25,000 deriv. | — |
| 2025-01-24 | Alexander Epshinsky | CFO | A | +29,496 | — |
| 2025-01-24 | Joseph Walter Vazzano | Director | A | +25,000 deriv. | — |
| 2025-01-24 | Laura Benjamin | Director | A | +25,000 deriv. | — |
| 2025-01-24 | Laura Benjamin | Director | A | +25,000 deriv. | — |
| 2025-01-24 | Gerald W. McLaughlin | Director | A | +25,000 deriv. | — |
| 2025-01-24 | Gerald W. McLaughlin | Director | A | +25,000 deriv. | — |
| 2025-01-24 | Thomas Jensen | CEO | A | +396,734 | — |
| 2025-01-24 | Jeremy R. Graff | CDO | A | +144,441 | — |
| 2024-10-01 | Jeremy R. Graff | See Remarks | A | +118,483 | +$250.00K |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| Thomas Jensen | CEO | 596,734 | $546.07K |
| Alexander Epshinsky | CFO | 85,051 | $77.83K |
| Gerald W. McLaughlin | Director | 70,000 | $64.06K |
| Jeremy R. Graff | See Remarks | 55,214 | $50.53K |
| Jesper Hoeiland | Director | 25,000 | $22.88K |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the ALLR quote page; the site-wide leaderboard is on the insider transactions hub.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.